Back to News
Market Impact: 0.2
Xylem Consensus Price Target Lowered by 12.92% to $126.34
Source: Nasdaq
Analyst EstimatesAnalyst Insights
Fintel-compiled aggregate analyst price targets for Xylem were revised to $126.34 per share, down 12.92% from the prior estimate of $145.08 dated October 20, 2026. The article provides no further context or company outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
XYL-0.30
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Apple reports after the bell. Options traders expect a big move
- Mizuho lowers Lumentum stock price target on Marvell acquisition
- Why is Apple stock falling afterhours today?
- RA Capital Management sells $9.13M in Lenz Therapeutics shares